Roanna Ruiz Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Roanna Ruiz

Stock Analyst at Leerink Partners

(3.7)
# 2473
Out of 5,477 analysts
79
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
XERS Xeris Biopharma Hold...
Maintains: Outperform
7 9
7.68 17.19% 7 Aug 19, 2025
AKBA Akebia Therapeutics
Initiates Coverage On: Outperform
7
2.99 134.11% 1 Apr 28, 2025
CRMD Cormedix
Initiates Coverage On: Outperform
18
13.09 37.51% 1 Mar 7, 2025
LXRX Lexicon Pharmaceutic...
Downgrades: Market Perform
1
1.11 -9.91% 1 Mar 4, 2025
VIR Vir Biotechnology
Maintains: Outperform
18 20
5.23 282.41% 4 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 27
10.15 166.01% 4 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 13
4.95 162.63% 3 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
6.68 109.58% 1 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
330
404.84 -18.49% 1 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
58
53.32 8.78% 1 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
25
74.33 -66.37% 1 Apr 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 2
2.18 -8.26% 4 Apr 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Perform
49
8.66 465.82% 10 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 13
5.63 130.91% 7 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
8 6
3.3 81.82% 6 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
19
26.6 -28.57% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
110 120
54.99 118.22% 3 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
75 50
10.88 359.56% 7 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
23 27
26.98 0.07% 7 Oct 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
60 40
14.97 167.2% 6 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
720 80
n/a n/a 3 Jul 14, 2022